Two competing pharmaceutical companies say they are going to work together to develop the first once-a-day pill to treat HIV - the virus that causes AIDS .,O O O O O O O O O O O O O O O O O O O B-nat O O O O O B-nat O,CD VBG JJ NNS VBP PRP VBP VBG TO VB RB TO VB DT JJ JJ NN TO VB NNP IN DT NN WDT VBZ NNP .
Briston-Myers Squibb and Gilead Sciences announced Monday they will collaborate to combine three separate drugs currently on the market into a single-dose pill that will make it easier for patients to manage their medication routine .,B-org I-org O B-org I-org O B-tim O O O O O O O O O O O O O O O O O O O O O O O O O O O O O,NNP NNP CC NNP NNP VBD NNP PRP MD VB TO VB CD JJ NNS RB IN DT NN IN DT JJ NN WDT MD VB PRP JJR IN NNS TO VB PRP$ NN NN .
Current treatment requires patients to take several pills a day .,O O O O O O O O O O O,JJ NN VBZ NNS TO VB JJ NNS DT NN .
Missing doses makes it easier for the virus to mutate and become resistant to medication .,O O O O O O O O O O O O O O O O,VBG NNS VBZ PRP JJR IN DT NN TO VB CC VB JJ TO NN .
"The companies say the planned once-a-day pill will combine Briston-Myers ' drug , Sustiva , with two drugs by Gilead - Viread and Emtriva .",O O O O O O O O O B-org O O O B-per O O O O O O O O O O O,"DT NNS VBP DT JJ JJ NN MD VB NNP POS NN , NNP , IN CD NNS IN NNP IN NNP CC NNP ."
The medicines attack the AIDS virus at different points in its replication cycle .,O O O O B-nat O O O O O O O O O,DT NNS VBP DT NNP NN IN JJ NNS IN PRP$ NN NN .
There is no cure for AIDS or HIV .,O O O O O B-nat O O O,EX VBZ DT NN IN NNP CC NNP .
